Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/25/2009US20090163504 Method for healing a wound using a phosphodiesterase type five inhibitor
06/25/2009US20090163503 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
06/25/2009US20090163502 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
06/25/2009US20090163501 Aurora kinase modulators and method of use
06/25/2009US20090163500 Compositions and methods for treating lysosomal disorders
06/25/2009US20090163499 Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists
06/25/2009US20090163498 Aryl Sulfonamides
06/25/2009US20090163497 Compounds Useful as Antagonists of CCR2
06/25/2009US20090163496 Antibacterial agents
06/25/2009US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
06/25/2009US20090163494 Protein kinase inhibitors
06/25/2009US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor
06/25/2009US20090163492 Substituted Oxindole Derivatives, Drugs Containing Said Derivatives and the Use Thereof
06/25/2009US20090163491 selective antagonists of A2B adenosine receptors; 6-Chloro-N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-pyridin-2-yl]-N-(2-pyridin-2-yl-ethyl)-nicotinamide; for treating asthma, diarrhea, insulin resistance, and diabetic retinopathy
06/25/2009US20090163490 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors
06/25/2009US20090163489 Inhibitors of PI3 kinase
06/25/2009US20090163488 Fused heterocycle derivatives and use thereof
06/25/2009US20090163487 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
06/25/2009US20090163486 Novel 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
06/25/2009US20090163485 Heteroaryl derivatives as orexin receptor antagonists
06/25/2009US20090163484 Pharmaceuticals containing fluoroquinolones
06/25/2009US20090163482 Tetralines antagonists of the h-3 receptor
06/25/2009US20090163481 Ppar-delta ligands and methods of their use
06/25/2009US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production
06/25/2009US20090163479 Use of taurolidine to treat tumors
06/25/2009US20090163478 Salts and Crystal Modifications Thereof
06/25/2009US20090163477 Phthalazinone derivatives
06/25/2009US20090163476 N-Phenyl Benzamide Derivatives as Sirtuin Modulators
06/25/2009US20090163475 Crystalline form of benzazepinium maleate derivative
06/25/2009US20090163474 FXR Agonists for the Treatment of Nonalcoholic Fatty Liver and Cholesterol Gallstone Diseases
06/25/2009US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES
06/25/2009US20090163472 Mineralocorticoid receptor antagonists and methods of use
06/25/2009US20090163471 Tropane compounds
06/25/2009US20090163470 Thiazolylidine urea and amide derivatives and methods of use thereof
06/25/2009US20090163469 Organic Compounds
06/25/2009US20090163468 Fused Bicyclic mTor Inhibitors
06/25/2009US20090163467 New compounds
06/25/2009US20090163466 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
06/25/2009US20090163465 Pyrimidines as PLK inhibitors
06/25/2009US20090163464 Benzothiazole and benzooxazole derivatives and methods of use
06/25/2009US20090163463 Organic Compounds
06/25/2009US20090163462 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
06/25/2009US20090163461 Ligand for Vesicular Acetylcholine Transporter
06/25/2009US20090163460 Diagnostics and therapeutics for early-onset menopause
06/25/2009US20090163459 Use of 24-nor-UDCA
06/25/2009US20090163458 Compositions and methods for treating Parkinson's disease and related disorders
06/25/2009US20090163457 Compositions and methods for delivering a biologically active agent
06/25/2009US20090163456 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists
06/25/2009US20090163455 Avermectin/hydrocortisone compositions for treating afflictions of the skin, e.g., rosacea
06/25/2009US20090163454 Methods of Step-Down Hormone Treatment
06/25/2009US20090163453 Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds
06/25/2009US20090163452 Compositions and methods for lowering serum cholesterol
06/25/2009US20090163451 Methods for treating visceral pain
06/25/2009US20090163450 Combinations comprising a prostaglandin and uses thereof
06/25/2009US20090163449 Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or additives
06/25/2009US20090163448 Diagnosis and treatment of human dormancy-related sequellae
06/25/2009US20090163447 Compositions for Drug Administration
06/25/2009US20090163446 Diazonamide analogs with improved solubility
06/25/2009US20090163444 Phospho-indoles as hiv inhibitors
06/25/2009US20090163443 from the culture of Streptomyces vayuensis strain; Nonadeca-6-enoic acid-3-(hexadecyloxy-hydroxy-thiophosphoryloxy)-quinoxalin-2-yl ester, useful particularly for prevention of obesity and treatment of diabetes, sleep apnea, nervous system, cardiovascular and gastrointestinal disorders
06/25/2009US20090163442 Treatment of cancer with 2-deoxygalactose
06/25/2009US20090163441 Hyaluronic Acid Binary Mixtures and Therapeutic Use Thereof
06/25/2009US20090163440 Ion-Channel Regulator Compositions and Methods of Using Same
06/25/2009US20090163439 Methods of using beta glucan as a radioprotective agent
06/25/2009US20090163438 Gankyrin
06/25/2009US20090163437 Steady-state subcutaneous administration of aptamers
06/25/2009US20090163436 Methods for delivery of nucleic acids
06/25/2009US20090163435 miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
06/25/2009US20090163433 Anthelmintic and/or insecticide development
06/25/2009US20090163432 Therapeutic Agent for Corneal Diseases
06/25/2009US20090163431 Compositions and methods for modulation of pdx-1
06/25/2009US20090163430 Functions and targets of let-7 micro rnas
06/25/2009US20090163429 Rna aptamers and methods for identifying the same
06/25/2009US20090163428 Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
06/25/2009US20090163407 Compositions and methods for altering wnt autocrine signaling
06/25/2009US20090163406 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells
06/25/2009US20090162458 Compositions and methods for inducing the expression of heat shock proteins
06/25/2009US20090162455 Feed for fish
06/25/2009US20090162454 Compositions and Methods for Effecting NAD+ Levels Using A Nicotinamide Phosphoribosyl Tranferase Inhibitor
06/25/2009US20090162451 Multilayer pellets containing water-soluble core, antagonist layer comprising naltrexone HCl coating, cationic sequestering polymer layer, agonist layer comprising morphine sulfate, and osmotic pressure regulating agent layer comprising sodium chloride
06/25/2009US20090162450 Multilayer pellets containing water-soluble core, antagonist layer comprising naltrexone HCl coating, cationic sequestering polymer layer, agonist layer comprising morphine sulfate, and osmotic pressure regulating agent layer comprising sodium chloride
06/25/2009US20090162449 Stable oral benzimidazole compositions and process of preparation thereof
06/25/2009US20090162447 Spherically Shaped Substances
06/25/2009US20090162444 Raloxifene composition
06/25/2009US20090162442 Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin
06/25/2009US20090162441 Pulmonary delivery in treating disorders of the central nervous system
06/25/2009US20090162440 Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof
06/25/2009US20090162438 Compositions and methods for joining non-conjoined lumens
06/25/2009US20090162434 Mesalazine tablet
06/25/2009US20090162433 Method of treatment
06/25/2009US20090162432 Stable laquinimod preparations
06/25/2009US20090162431 Sustained release formulations containing acetaminophen and tramadol
06/25/2009US20090162425 Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents
06/25/2009US20090162423 Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers
06/25/2009US20090162421 Drugs as well as their production and use in the treatment of pain-associated neuropathies
06/25/2009US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids
06/25/2009US20090162413 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices
06/25/2009US20090162412 Implantable polymeric device for sustained release of dopamine agonist
06/25/2009US20090162407 Process for preparing microparticles having a low residual solvent volume
06/25/2009US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
1 ... 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 ... 7860